Form 424B5 - Prospectus [Rule 424(b)(5)]
SEC Accession No. 0001213900-26-059114
Filing Date
2026-05-19
Accepted
2026-05-19 17:10:18
Documents
13

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea0291272-424b5_regencell.htm 424B5 571144
2 FILING FEE TABLE ea029127201ex-fee.htm   iXBRL EX-FILING FEES 13977
3 GRAPHIC ea029127201_img1.jpg GRAPHIC 18874
4 GRAPHIC ea029127201_img2.jpg GRAPHIC 18874
  Complete submission text file 0001213900-26-059114.txt   761711

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT ea029127201ex-fee_htm.xml XML 4981
Mailing Address 9/F CHINACHEM LEIGHTON PLAZA 29 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG China
Business Address 9/F CHINACHEM LEIGHTON PLAZA 29 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG China 852 2155 0823
Regencell Bioscience Holdings Ltd (Filer) CIK: 0001829667 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9
Type: 424B5 | Act: 33 | File No.: 333-294722 | Film No.: 261000224
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)